Cargando…
Refractory Duodenal Crohn's Disease Successfully Treated with Infliximab
Crohn's disease (CD) may involve any part of the gastrointestinal tract, from the mouth to the anus. Approximately >90% of cases occur in the small bowel and colon. Upper gastrointestinal involvement, especially duodenal manifestation, is relatively rare. Therefore, adequate medical treatmen...
Autores principales: | Kim, You Lim, Park, Young Sook, Park, Eun Kyoung, Park, Dae Rim, Choi, Gyu Sik, Ahn, Sang Bong, Kim, Seong Hwan, Jo, Yun Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204694/ https://www.ncbi.nlm.nih.gov/pubmed/25349566 http://dx.doi.org/10.5217/ir.2014.12.1.66 |
Ejemplares similares
-
Successful Treatment of Postoperative Fistula with Infliximab in a Patient with Crohn's Disease
por: Jeong, Seong Yeon, et al.
Publicado: (2014) -
Co-existence of relapsing polychondritis and Crohn disease treated successfully with infliximab
por: Jung, Hye-In, et al.
Publicado: (2020) -
Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease
por: Oh, Eun Hye, et al.
Publicado: (2017) -
A Case Report of Primary Duodenal Tuberculosis Mimicking a Malignant Tumor
por: Jung, Ji Hye, et al.
Publicado: (2014) -
Subcutaneous Infliximab in Refractory Crohn’s Disease Patients: A Possible Biobetter?
por: Cerna, Karin, et al.
Publicado: (2023)